Company · CIK 1280600
ACCELERON PHARMA INC
| CIK | 1280600 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2013-11-14 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-220522 | 2017-09-19 | 2020-06-29 | 4 | |
| 333-208845 | 2016-01-04 | 2016-01-06 | 3 | |
| 333-193252 | 2014-01-09 | 2014-01-23 | 4 | |
| 333-190417 | 2013-08-07 | 2013-09-19 | 5 |
Filings
17| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2020-06-29 | 424B5Shelf takedown | 333-220522 | 0001047469-20-003908 |
| 2019-01-14 | 424B5Shelf takedown | 333-220522 | 0001047469-19-000121 |
| 2017-09-19 | 424B5Shelf takedown | 333-220522 | 0001047469-17-005962 |
| 2017-09-19 | S-3ASRShelf registered | 333-220522 | 0001047469-17-005957 |
| 2016-01-06 | 424B5Shelf takedown | 333-208845 | 0001047469-16-009571 |
| 2016-01-04 | 424B5Shelf takedown | 333-208845 | 0001047469-16-009539 |
| 2016-01-04 | S-3ASRShelf registered | 333-208845 | 0001047469-16-009526 |
| 2014-01-23 | 424B4Final prospectus | 333-193252 | 0001047469-14-000314 |
| 2014-01-22 | EFFECTDeclared effective | 333-193252 | 9999999995-14-000180 |
| 2014-01-21 | S-1/AAmendment | 333-193252 | 0001047469-14-000238 |
| 2014-01-09 | S-1Registration filed | 333-193252 | 0001047469-14-000098 |
| 2013-09-19 | 424B4Final prospectus | 333-190417 | 0001047469-13-009174 |
| 2013-09-18 | EFFECTDeclared effective | 333-190417 | 9999999995-13-002703 |
| 2013-09-06 | S-1/AAmendment | 333-190417 | 0001047469-13-008888 |
| 2013-08-20 | S-1/AAmendment | 333-190417 | 0001047469-13-008540 |
| 2013-08-07 | S-1Registration filed | 333-190417 | 0001047469-13-008148 |
| 2013-07-03 | DRSDraft made public | 377-00232 | 0000912057-13-000222 |